ONCOPRO LIQUID BIOPSY 73 Gene Panel with MSI

This test is used for detection of somatic mutations and for personalized medicine using circulating tumor DNA (ctDNA). It expands treatment options and provides therapy monitoring and management solutions. This test detects somatic mutations in 73 genes, including oncogenes, tumor suppressor genes, and tumor stimulator genes . It detects multiple types of genomic alterations, including copy number variation (CNV), insertions and deletions.

  • Test Type:
  • Pre-test Information:
    OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory
  • Report Delivery:
    Sample Daily by 9 am; Report 35 days
  • Components:
    0